IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP

Watchlist Manager
IOL Chemicals and Pharmaceuticals Ltd Logo
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Watchlist
Price: 66.73 INR 3.63% Market Closed
Market Cap: 19.6B INR

During the last 3 months IOL Chemicals and Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 13% over this period (open performance analysis).

The last transaction was made on Aug 24, 2021 by Damandeep Singh (Chief Executive Officer (CEO)) , who sold 1.4m INR worth of IOLCP shares.

Last Transactions:
Damandeep Singh
Chief Executive Officer (CEO)
₹-1.4m
Damandeep Singh
Chief Executive Officer (CEO)
₹-2.1m
Damandeep Singh
Chief Executive Officer (CEO)
₹-990k
Damandeep Singh
Chief Executive Officer (CEO)
₹-2.5m
Ncvi Enterprises Limited
₹+82m
Ncvi Enterprises Limited
₹+290.7m
Towels Enterprises Limited
₹+139.8m
Damandeep Singh
Chief Executive Officer (CEO)
₹+1.5m
True Value Traders Limited
₹+25.2m
Towels Enterprises Limited
₹+19.7m
View All Transactions

During the last 3 months IOL Chemicals and Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 13% over this period (open performance analysis).

The last transaction was made on Aug 24, 2021 by Damandeep Singh (Chief Executive Officer (CEO)) , who sold 1.4m INR worth of IOLCP shares.

Sold
0-3
months
0 INR
0
3-6
months
0 INR
0
6-9
months
0 INR
0
9-12
months
0 INR
0
Bought
0-3
months
No Insider Transactions
0
0 INR
3-6
months
No Insider Transactions
0
0 INR
6-9
months
No Insider Transactions
0
0 INR
9-12
months
No Insider Transactions
0
0 INR

IOL Chemicals and Pharmaceuticals Ltd
Insider Trading Chart

IOL Chemicals and Pharmaceuticals Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

IOL Chemicals and Pharmaceuticals Ltd
Last Insider Transactions

Global
Insiders Monitor

IOL Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
19.6B INR
Industry
Pharmaceuticals

IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

IOLCP Intrinsic Value
64.93 INR
Overvaluation 3%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top